
{
  "symbol": "PRME",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "small-cap company", "gene editing technology"],
    "riskScore": 7,
    "reason": "Prime Medicine operates in the biotechnology sector with a focus on gene editing, making it susceptible to social media hype and speculative trading."
  }
}
